按等级 发表于 2025-3-23 12:48:47

Submitted on: 11 November 2024.
Revised on: 07 March 2025.
Accepted on: 26 April 2025.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS

Communicate 发表于 2025-3-23 17:16:32

http://reply.papertrans.cn/2/149/14855/14855-12.png

服从 发表于 2025-3-23 19:41:19

http://reply.papertrans.cn/2/149/14855/14855-13.png

Postmenopause 发表于 2025-3-24 01:40:36

Submitted on: 21 March 2011.
Revised on: 09 July 2011.
Accepted on: 26 July 2011.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS

Tempor 发表于 2025-3-24 05:08:26

Submitted on: 16 October 2005.
Revised on: 17 December 2005.
Accepted on: 30 December 2005.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS

RODE 发表于 2025-3-24 08:40:34

Submitted on: 24 November 2014.
Revised on: 08 February 2015.
Accepted on: 07 March 2015.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS

织布机 发表于 2025-3-24 12:45:50

http://reply.papertrans.cn/2/149/14855/14855-17.png

RADE 发表于 2025-3-24 15:07:37

Submitted on: 26 June 2021.
Revised on: 23 August 2021.
Accepted on: 05 October 2021.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS

HUMP 发表于 2025-3-24 19:13:31

http://reply.papertrans.cn/2/149/14855/14855-19.png

从属 发表于 2025-3-25 01:30:49

Submitted on: 05 November 1998.
Revised on: 15 December 1998.
Accepted on: 26 January 1999.

___________________JBI Evidence Implementation---LIPPINCOTT WILLIAMS & WILKINS
页: 1 [2] 3 4
查看完整版本: SCIE期刊JBI Evidence Implementation 2024/2025影响因子:2.797 (JBI EVID IMPLEMENT) (2691-3321). (MEDICINE, GENERAL & INTERNAL)(